HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Theodore F Reiss Selected Research

montelukast (Singulair)

1/2021Pilot Study of Peak Plasma Concentration After High-Dose Oral Montelukast in Children With Acute Asthma Exacerbations.
1/2018Adverse events are rare after single-dose montelukast exposures in children.
12/2016Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood.
4/2012Airway obstruction lability helps distinguish levels of disease activity in asthma.
6/2011Intermittent or daily montelukast versus placebo for episodic asthma in children.
6/2011The efficacy and tolerability of inhaled montelukast plus inhaled mometasone compared with mometasone alone in patients with chronic asthma.
12/2010A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.
2/2010A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma.
11/2009Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
11/2009Clinical studies of the DP1 antagonist laropiprant in asthma and allergic rhinitis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Theodore F Reiss Research Topics

Disease

24Asthma (Bronchial Asthma)
01/2021 - 01/2002
11Allergic Rhinitis
01/2018 - 06/2002
7Seasonal Allergic Rhinitis (Hay Fever)
11/2009 - 06/2002
4Rhinitis
11/2009 - 06/2002
3Bronchiolitis
12/2016 - 04/2008
3Airway Obstruction (Choking)
04/2012 - 08/2002
3Hypersensitivity (Allergy)
05/2007 - 03/2004
2Inflammation (Inflammations)
01/2022 - 12/2005
2Chronic Obstructive Pulmonary Disease (COPD)
03/2011 - 03/2009
2Perennial Allergic Rhinitis
05/2007 - 12/2005
2Sneezing
12/2005 - 03/2004
2Rhinorrhea
12/2005 - 03/2004
2Pruritus (Itching)
12/2005 - 03/2004
1Fibrosis (Cirrhosis)
01/2022
1Pulmonary Fibrosis (Fibrosing Alveolitis)
01/2022
1Disease Progression
01/2022
1Fever (Fevers)
06/2009
1Pharyngitis (Sore Throat)
06/2009
1Infections
06/2009
1Overactive Urinary Bladder (Overactive Bladder)
12/2006
1Urge Urinary Incontinence (Urge Incontinence)
12/2006
1Wounds and Injuries (Trauma)
08/2002
1Foreign Bodies (Foreign Body)
08/2002
1Asphyxia (Suffocation)
08/2002

Drug/Important Bio-Agent (IBA)

29montelukast (Singulair)FDA Link
01/2021 - 01/2002
7AllergensIBA
11/2009 - 02/2003
6Adrenal Cortex Hormones (Corticosteroids)IBA
06/2011 - 02/2003
5Leukotriene Antagonists (Leukotriene Receptor Antagonists)IBA
01/2018 - 01/2002
5LeukotrienesIBA
01/2012 - 01/2002
3Loratadine (Alavert)FDA Link
11/2009 - 06/2002
2Lipoxygenase InhibitorsIBA
01/2012 - 03/2011
2Pharmaceutical PreparationsIBA
11/2009 - 08/2002
1Antifibrotic AgentsIBA
01/2022
1CC-90001IBA
01/2022
1CollagenIBA
01/2022
1Phosphotransferases (Kinase)IBA
01/2022
1Protein Kinases (Protein Kinase)IBA
01/2022
1JNK Mitogen-Activated Protein KinasesIBA
01/2022
1Interleukin-5 (Interleukin 5)IBA
12/2016
1Interleukin-18 (Interleukin 18)IBA
12/2016
1Interleukin-16 (Interleukin 16)IBA
12/2016
1Biomarkers (Surrogate Marker)IBA
12/2016
1Leukotriene B4IBA
01/2012
1Mometasone Furoate (Nasonex)FDA LinkGeneric
06/2011
13- (2- (4- azidobenzamidino)ethyl)- 5- hydroxyindole (SABA)IBA
06/2011
1Cetirizine (Zyrtec)FDA LinkGeneric
11/2009
1ProstaglandinsIBA
11/2009
1MK-0524IBA
11/2009
1Beclomethasone (Beclometasone)FDA Link
06/2009
1Phosphodiesterase 4 InhibitorsIBA
03/2009
1Type 4 Cyclic Nucleotide PhosphodiesterasesIBA
03/2009
1Budesonide (Pulmicort)FDA LinkGeneric
09/2007
1PowdersIBA
09/2007
1Aprepitant (Emend)FDA Link
12/2006
1Capsules (Microcapsules)IBA
12/2006
1TachykininsIBA
12/2006
1Neurokinin-1 Receptors (Neurokinin 1 Receptor)IBA
12/2006
1Neurokinin-1 Receptor AntagonistsIBA
12/2006
1Oxygen (Dioxygen)IBA
02/2003
1leukotriene D4 receptor (cysteinyl leukotriene receptor)IBA
02/2003
1TabletsIBA
08/2002
1Histamine (Histamine Dihydrochloride)FDA Link
06/2002
1Bronchodilator Agents (Bronchodilators)IBA
01/2002
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2002

Therapy/Procedure

10Therapeutics
12/2016 - 04/2002
1Airway Management
04/2012